BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 33842214)

  • 1. Contemporary outcomes of continuous-flow left ventricular assist devices-a systematic review.
    McNamara N; Narroway H; Williams M; Brookes J; Farag J; Cistulli D; Bannon P; Marasco S; Potapov E; Loforte A
    Ann Cardiothorac Surg; 2021 Mar; 10(2):186-208. PubMed ID: 33842214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous-flow left ventricular assist device versus orthotopic heart transplantation in adults with heart failure: a systematic review and meta-analysis.
    Zhang B; Guo S; Ning J; Li Y; Liu Z
    Ann Cardiothorac Surg; 2021 Mar; 10(2):209-220. PubMed ID: 33842215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center.
    Park Y; Kim D; Yang JH; Cho YH; Choi JO; Jeon ES
    Korean J Intern Med; 2022 Mar; 37(2):340-349. PubMed ID: 34871480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary outcomes of continuous-flow biventricular assist devices.
    Farag J; Woldendorp K; McNamara N; Bannon PG; Marasco SF; Loforte A; Potapov EV
    Ann Cardiothorac Surg; 2021 May; 10(3):311-328. PubMed ID: 34159113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    Ann Thorac Surg; 2019 Feb; 107(2):341-353. PubMed ID: 30691584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between novel clinical factors and gastrointestinal bleeding among patients supported with continuous-flow left ventricular assist device therapy.
    Thohan V; Shi Y; Rappelt M; Yousefzai R; Sulemanjee NZ; Hastings TE; Cheema OM; Downey F; Crouch JD
    J Card Surg; 2019 Jun; 34(6):453-462. PubMed ID: 31058372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporary left ventricular assist devices as a bridge to heart transplantation.
    Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
    J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Assist Devices Impact Hospital Resource Utilization Without Affecting Patient Mortality in Gastrointestinal Bleeding.
    Li F; Hinton A; Chen A; Mehta NK; Eldika S; Zhang C; Hussan H; Conwell DL; Krishna SG
    Dig Dis Sci; 2017 Jan; 62(1):150-160. PubMed ID: 27858326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention.
    Harvey L; Holley CT; John R
    Ann Cardiothorac Surg; 2014 Sep; 3(5):475-9. PubMed ID: 25452907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short and long term outcomes of 200 patients supported by continuous-flow left ventricular assist devices.
    Tsiouris A; Paone G; Nemeh HW; Borgi J; Williams CT; Lanfear DE; Morgan JA
    World J Cardiol; 2015 Nov; 7(11):792-800. PubMed ID: 26635927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients on heart transplant list treated with a continuous-flow left ventricular assist device: Insights from the TRans-Atlantic registry on VAd and TrAnsplant (TRAViATA).
    Ammirati E; Brambatti M; Braun OÖ; Shah P; Cipriani M; Bui QM; Veenis J; Lee E; Xu R; Hong KN; Van de Heyning CM; Perna E; Timmermans P; Cikes M; Brugts JJ; Veronese G; Minto J; Smith S; Gjesdal G; Gernhofer YK; Partida C; Potena L; Masetti M; Boschi S; Loforte A; Jakus N; Milicic D; Nilsson J; De Bock D; Sterken C; Van den Bossche K; Rega F; Tran H; Singh R; Montomoli J; Mondino M; Greenberg B; Russo CF; Pretorius V; Liviu K; Frigerio M; Adler ED
    Int J Cardiol; 2021 Feb; 324():122-130. PubMed ID: 32950592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.